| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8827916 | European Urology Focus | 2017 | 4 Pages |
Abstract
Systemic therapies can lead to heterogeneous responses in individual metastases of prostate cancer in a patient. Molecular imaging may be useful for identifying heterogeneity and could allow targeted biopsy for molecular analysis or therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Fannie Morin, Jean-Mathieu Beauregard, Michelle Bergeron, Molière Nguile Makao, Louis Lacombe, Vincent Fradet, Yves Fradet, Frédéric Pouliot,